Search Results - "Padrão, Eduardo Lanza"

Refine Results
  1. 1
  2. 2

    Post I-131 Therapy Scanning in Patients With Thyroid Carcinoma Metastases: An Unnecessary Cost or a Relevant Contribution? by Souza Rosário, Pedro Wesley, Barroso, Álvaro Luís, Rezende, Leonardo Lamego, Padrão, Eduardo Lanza, Fagundes, Tales Alvarenga, Penna, Gustavo Cancela, Purisch, Saulo

    Published in Clinical nuclear medicine (01-12-2004)
    “…RATIONALE:In patients with elevated serum thyroglobulin (Tg) and a negative whole-body scan (WBS), posttherapy scanning can reveal metastases in many cases and…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Thyroglobulin before Ablation and Correlation with Posttreatment Scanning by Souza Rosário, Pedro Weslley, Guimarães, Valéria C., Ribeiro Maia, Frederico Fernandes, Fagundes, Tales Alvarenga, Purisch, Saulo, Padrao, Eduardo Lanza, Rezende, Leonardo Lamego, Barroso, Alvaro Luis

    Published in The Laryngoscope (01-02-2005)
    “…Objectives/Hypothesis: To determine the usefulness of thyroglobulin (Tg) before ablation and the correlation with posttreatment scanning in patients with…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Malformations in the offspring of women with thyroid cancer treated with radioiodine for the ablation of thyroid remnants by do Rosário, Pedro Weslley S, Barroso, Alvaro Luís, Rezende, Leonardo Lamego, Padrão, Eduardo Lanza, Borges, Michelle A Ribeiro, Purisch, Saulo

    “…Since ovarian function is only temporarily compromised by radioiodine therapy, many women with thyroid cancer treated with radioiodine can become pregnant. The…”
    Get full text
    Journal Article
  8. 8

    Correlation Between Cervical Uptake and Results of Postsurgical Radioiodine Ablation in Patients With Thyroid Carcinoma by Rosário, Pedro W. S, Maia, Frederico Fernandes Ribeiro, Cardoso, Ludmilla David, Barroso, Álvaro, Rezende, Leonardo, Padrão, Eduardo Lanza, Purisch, Saulo

    Published in Clinical nuclear medicine (01-06-2004)
    “…OBJECTIVE:The objective of this study was to determine the relationship between cervical uptake after thyroidectomy and the success of treatment of cervical…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Valor da varredura com iodo antes da terapia ablativa em pacientes com carcinoma de tireóide by Rosário, Pedro Weslley Souza do, Cardoso, Ludmilla David, Fagundes, Tales Alvarenga, Barroso, Álvaro Luís, Rezende, Leonardo Lamego, Padrão, Eduardo Lanza, Purisch, Saulo

    Published in Radiologia brasileira (01-08-2005)
    “…OBJETIVO: Avaliar a relevância clínica da varredura pré-dose ablativa em pacientes com carcinoma diferenciado de tireóide. MATERIAIS E MÉTODOS: Analisamos a…”
    Get full text
    Journal Article
  11. 11

    Valor da varredura com iodo antes da terapia ablativa em pacientes com carcinoma de tireóide by Rosário, Pedro Weslley Souza do, Cardoso, Ludmilla David, Fagundes, Tales Alvarenga, Barroso, Álvaro Luís, Rezende, Leonardo Lamego, Padrão, Eduardo Lanza, Purisch, Saulo

    Published in Radiologia brasileira (01-08-2005)
    “…OBJETIVO: Avaliar a relevância clínica da varredura pré-dose ablativa em pacientes com carcinoma diferenciado de tireóide. MATERIAIS E MÉTODOS: Analisamos a…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Recombinant TSH in ablative therapy and follow-up of patients with differentiated thyroid carcinoma by Rosário, Pedro Weslley S do, Fagundes, Tales Alvarenga, Purisch, Saulo, Padrão, Eduardo Lanza, Rezende, Leonardo Lamego, Barroso, Alvaro Luís

    “…The studies evaluating the efficacy and safety of recombinant TSH in the ablative therapy and follow-up of patients with differentiated thyroid carcinoma by…”
    Get full text
    Journal Article
  15. 15

    TSH recombinante no tratamento e seguimento de pacientes com carcinoma diferenciado de tireóide: uso na prática clínica by Rosário, Pedro Weslley S. do, Fagundes, Tales Alvarenga, Purisch, Saulo, Padrão, Eduardo Lanza, Rezende, Leonardo Lamego, Barroso, Álvaro Luís

    “…Os estudos que avaliaram a eficácia e segurança do TSH recombinante no preparo dos pacientes com carcinoma diferenciado de tireóide (CDT) para o tratamento…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    5 mCi pretreatment scanning does not cause stunning when the ablative dose is administered within 72 hours by Rosário, Pedro Weslley S, Barroso, Alvaro Luís, Rezende, Leonardo L, Padrão, Eduardo Lanza, Maia, Frederico F Ribeiro, Fagundes, Tales A, Purisch, Saulo

    “…To determine the stunning effect of a tracer dose of 5 mCi iodine-131. We retrospectively analyzed 145 patients who received the first ablative treatment at…”
    Get full text
    Journal Article
  19. 19

    5mCi pretreatment scanning does not cause stunning when the ablative dose is administered within 72 hours by Rosário, Pedro Weslley S., Barroso, Álvaro Luís, Rezende, Leonardo L., Padrão, Eduardo Lanza, Maia, Frederico F. Ribeiro, Fagundes, Tales A., Purisch, Saulo

    “…OBJECTIVE: To determine the stunning effect of a tracer dose of 5mCi iodine-131. PATIENTS AND METHODS: We retrospectively analyzed 145 patients who received…”
    Get full text
    Journal Article
  20. 20

    Revisitando a tireoglobulina sérica no seguimento de pacientes com carcinoma diferenciado de tireóide by Rosário, Pedro Weslley S., Cardoso, Ludmilla David, Fagundes, Tales Alvarenga, Barroso, Álvaro Luís, Padrão, Eduardo Lanza, Rezende, Leonardo Lamego, Purisch, Saulo

    “…Este estudo avaliou a tireoglobulina (Tg) sérica dosada em hipotireoidismo em 207 pacientes com carcinoma diferenciado de tireóide tratados com tireoidectomia…”
    Get full text
    Journal Article